Tonix Pharmaceuticals Holding Corp (TNXP) Showcases Promising TNX-801 Vaccine Data
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 468,712 | $6,444,790 | 0% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 313,082 | $4,304,878 | +69% | 0.01% |
| 3. | Millennium Management Israel Englander | 219,673 | $3,020,504 | +858% | 0% |
| 4. | AQR Capital Management Cliff Asness | 161,208 | $2,216,611 | +706% | 0% |
| 5. | Point72 Asset Management Steve Cohen | 125,414 | $1,724,443 | -80% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.62 | 5,000 | $63,100.00 | 20,001 | 2026-03-31 | Filing | |
| $14.89 | 15,000 | $223,350.00 | 15,001 | 2026-03-18 | Filing | |
| $36.03 | 418 | $15,060.54 | 418 | 2025-08-21 | Filing | |
| $36.00 | 250 | $9,000.00 | 250 | 2025-08-20 | Filing | |
| $21.55 | 4,000 | $86,200.00 | 4,005 | 2025-05-15 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.46 | 5,000 | $17,300.00 | 23,500 | 2017-12-21 | Filing | |
| $3.44 | 8,965 | $30,839.60 | 28,500 | 2017-12-20 | Filing | |
| $3.51 | 6,035 | $21,182.85 | 37,465 | 2017-12-19 | Filing | |
| $3.57 | 10,000 | $35,700.00 | 43,500 | 2017-12-18 | Filing | |
| $3.55 | 5,000 | $17,750.00 | 53,500 | 2017-12-15 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 968,177 | $13,312,434 | 0% | |
| 2. | 518,650 | $7,131,438 | 0% | |
| 3. | 452,116 | $6,216,595 | 1.33% | |
| 4. | 313,291 | $4,308,912 | 0% | |
| 5. | 231,678 | $3,185,573 | 0% |